The efficacy and safety of different bismuth agents in Helicobacter pylori first-line eradication: A multicenter, randomized, controlled clinical trial.
Medicine (Baltimore)
; 100(50): e27923, 2021 Dec 17.
Article
in En
| MEDLINE
| ID: mdl-34918639
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bismuth
/
Helicobacter pylori
/
Helicobacter Infections
/
Anti-Bacterial Agents
Type of study:
Clinical_trials
/
Guideline
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Medicine (Baltimore)
Year:
2021
Document type:
Article
Affiliation country:
China
Country of publication:
United States